David J Galvin
Overview
Explore the profile of David J Galvin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
179
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jalali A, Foley R, Maweni R, Murphy K, Lundon D, Lynch T, et al.
BMC Med Inform Decis Mak
. 2020 Jul;
20(1):148.
PMID: 32620120
Background: Prostate cancer (PCa) represents a significant healthcare problem. The critical clinical question is the need for a biopsy. Accurate risk stratification of patients before a biopsy can allow for...
2.
Croghan S, Zaborowski A, Mohan H, Mulvin D, McGuire B, Murphy M, et al.
Int J Colorectal Dis
. 2019 Jun;
34(7):1161-1178.
PMID: 31175421
Purpose: 'Prophylactic' ureteric stents potentially reduce rates, and facilitate intraoperative recognition, of iatrogenic ureteric injury (IUI) during colorectal resections. A lack of consensus surrounds the risk-benefit equation of this practice,...
3.
4.
Croghan S, Matanhelia D, Foran A, Galvin D
Surg J (N Y)
. 2018 Dec;
4(4):e226-e234.
PMID: 30574556
There is a little published data on the outcomes of radical prostatectomy in the Irish context. We aimed to determine the 5-year oncological results of open radical retropubic prostatectomy (RRP)...
5.
Browne C, Davis N, Nolan W, MacCraith E, Lennon G, Mulvin D, et al.
Curr Urol
. 2017 Sep;
10(3):132-135.
PMID: 28878595
Introduction: Neoadjuvant chemotherapy (NAC) confers a significant survival benefit in patients with muscle invasive bladder cancer. Platinum-based chemotherapy increases the risk of thromboembolic events (TEE). We determined the effect of...
6.
MacCraith E, Davis N, Browne C, Galvin D, Quinlan D, Lennon G, et al.
J Clin Diagn Res
. 2016 Nov;
10(10):PC15-PC17.
PMID: 27891391
Introduction: Knowledge on health economics among urology trainees is not formally assessed. The cost of commonly utilised endourological devices may not be considered by trainees. Aim: The present study was...
7.
Foley R, Maweni R, Gorman L, Murphy K, Lundon D, Durkan G, et al.
BJU Int
. 2016 Feb;
118(5):706-713.
PMID: 26833820
Objective: To analyse the performance of the Prostate Cancer Prevention Trial Risk Calculator (PCPT-RC) and two iterations of the European Randomised Study of Screening for Prostate Cancer (ERSPC) Risk Calculator,...
8.
Nason G, Walsh L, Redmond C, Kelly N, McGuire B, Sharma V, et al.
Can Urol Assoc J
. 2015 Oct;
9(9-10):E583-8.
PMID: 26425218
Introduction: We compare the survival outcomes of patients with clear cell renal cell carcinoma (RCC) treated with adrenal sparing radical nephrectomy (ASRN) and non-adrenal sparing radical nephrectomy (NASRN). Methods: We...
9.
Nason G, McGuire B, Kelly M, Murphy T, Looney A, Byrne D, et al.
Can Urol Assoc J
. 2014 May;
8(3-4):125-32.
PMID: 24839483
Introduction: Renal cell carcinoma (RCC) represents about 3% of adult malignancies in Ireland. Worldwide there is a reported increasing incidence and recent studies report a stage migration towards smaller tumours....
10.
Nason G, McGuire B, Liddy S, Looney A, Lennon G, Mulvin D, et al.
Can Urol Assoc J
. 2013 Sep;
7(7-8):252-7.
PMID: 24032060
Introduction: Fracture of the penis is a rare urological emergency which occurs as a result of abrupt trauma to an erect penis. There is paucity of data regarding long-term sexual...